Citation: K. Overgaard et P. Meden, CEREBRAL BLOOD-FLOW MEASUREMENT DURING EMBOLIZATION OF THE RAT-BRAIN USING THE XENON INJECTION METHOD, Neurological research, 20(5), 1998, pp. 452-462
Authors:
KASTE M
MAU J
BLUHMKI E
DELZOPPO GJ
ORGOGOZO JM
OVERGAARD K
VONKUMMER R
WAHLGREN NG
Citation: M. Kaste et al., RISK BENEFIT ASSESSMENT FOR MORTALITY AND HANDICAP IN 615 ECASS RANDOMIZED AND TREATED PATIENTS - A POST-HOC ANALYSIS/, Stroke, 29(1), 1998, pp. 81-81
Authors:
OVERGAARD K
SEREGHY T
PEDERSEN H
BOYSEN G
Citation: K. Overgaard et al., EFFECT OF DELAYED THROMBOLYSIS WITH RT-PA IN A RAT EMBOLIC STROKE MODEL (VOL 14, PG 472, 1994), Journal of cerebral blood flow and metabolism, 17(5), 1997, pp. 596-596
Citation: T. Sereghy et al., NEUROPROTECTION BY EXCITATORY AMINO-ACID ANTAGONIST AUGMENTS THE BENEFIT OF THROMBOLYSIS IN EMBOLIC STROKE IN RATS (VOL 24, PG 1702, 1993), Stroke, 28(2), 1997, pp. 466-466
Citation: K. Overgaard et al., EFFECTS OF REDUCED ELECTROCHEMICAL NA-MUSCLE - ROLE OF THE NA+-K+ PUMP( GRADIENT ON CONTRACTILITY IN SKELETAL), Pflugers Archiv, 434(4), 1997, pp. 457-465
Authors:
OVERGAARD K
NIELSEN OB
FLATMAN JA
CLAUSEN T
Citation: K. Overgaard et al., NA-K+ PUMP STIMULATION INDUCES RECOVERY OF M-WAVE AND TETANIC FORCE IN RAT SOLEUS MUSCLES AT REDUCED NA+()K+ GRADIENTS/, Journal of physiology, 504P, 1997, pp. 231-232
Citation: Al. Poulsen et al., BONE METABOLISM FOLLOWING BLADDER SUBSTITUTION WITH THE ILEAL URETHRAL KOCK RESERVOIR, British Journal of Urology, 79(3), 1997, pp. 339-347
Authors:
RAVN P
FLEDELIUS C
ROSENQUIST C
OVERGAARD K
CHRISTIANSEN C
Citation: P. Ravn et al., HIGH BONE TURNOVER IS ASSOCIATED WITH LOW BONE MASS IN BOTH PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN, Bone, 19(3), 1996, pp. 291-298
Authors:
RIIS BJ
HANSEN MA
JENSEN AM
OVERGAARD K
CHRISTIANSEN C
Citation: Bj. Riis et al., LOW BONE MASS AND FAST RATE OF BONE LOSS AT MENOPAUSE - EQUAL RISK-FACTORS FOR FUTURE FRACTURE - A 15-YEAR FOLLOW-UP-STUDY, Bone, 19(1), 1996, pp. 9-12
Authors:
NILAS L
MARSLEV U
OVERGAARD K
CHRISTIANSEN C
Citation: L. Nilas et al., MARKERS OF BONE TURNOVER AND RATES OF BONE LOSS DURING 3 YEARS COMBINED HORMONE REPLACEMENT THERAPY, Menopause, 3(4), 1996, pp. 190-196
Citation: P. Meden et al., EFFECT OF EARLY TREATMENT WITH TIRILAZAD (U74006F) COMBINED WITH DELAYED THROMBOLYTIC THERAPY IN RAT EMBOLIC STROKE, Cerebrovascular diseases, 6(3), 1996, pp. 141-148
Authors:
RAVN P
OVERGAARD K
HUANG C
ROSS PD
GREEN D
MCCLUNG M
Citation: P. Ravn et al., COMPARISON OF BONE DENSITOMETRY OF THE PHALANGES, DISTAL FOREARM AND AXIAL SKELETON IN EARLY POSTMENOPAUSAL WOMEN PARTICIPATING IN THE EPICSTUDY, Osteoporosis international, 6(4), 1996, pp. 308-313
Authors:
VONDERRECKE P
HANSEN MA
OVERGAARD K
CHRISTIANSEN C
Citation: P. Vonderrecke et al., THE IMPACT OF DEGENERATIVE CONDITIONS IN THE SPINE ON BONE-MINERAL DENSITY AND FRACTURE RISK PREDICTION, Osteoporosis international, 6(1), 1996, pp. 43-49
Authors:
WANG Q
RAVN P
WANG S
OVERGAARD K
HASSAGER C
CHRISTIANSEN C
Citation: Q. Wang et al., BONE-MINERAL DENSITY IN IMMIGRANTS FROM SOUTHERN CHINA TO DENMARK - ACROSS-SECTIONAL STUDY, European journal of endocrinology, 134(2), 1996, pp. 163-167
Citation: K. Overgaard et C. Christiansen, A NEW BIOCHEMICAL MARKER OF BONE-RESORPTION FOR FOLLOW-UP ON TREATMENT WITH NASAL SALMON-CALCITONIN, Calcified tissue international, 59(1), 1996, pp. 12-16
Authors:
KASTE M
OVERGAARD K
DELZOPPO G
VONKUMMER R
ORGOGOZO JM
WHALGREEN NG
BLUHMKI E
MAU J
Citation: M. Kaste et al., WHO BENEFITS AND WHO SUFFERS FROM IV RECOMBINANT TISSUE-PLASMINOGEN ACTIVATOR (RT-PA) IN ISCHEMIC HEMISPHERIC STROKE - SUBGROUP ANALYSES OFECASS, Stroke, 27(1), 1996, p.
Citation: K. Overgaard et al., INHIBITORY EFFECTS OF CHANGES IN EXTRACELLULAR NA-K+ PUMP( AND K+ ON FORCE DEVELOPMENT IN RAT SOLEUS MUSCLE EXHIBIT SYNERGY, AND ARE ALLEVIATED BY ACUTE STIMULATION OF THE NA+), Journal of physiology, 491P, 1996, pp. 131-131
Authors:
OVERGAARD K
ALEXANDERSEN P
RIIS BJ
CHRISTIANSEN C
Citation: K. Overgaard et al., EVALUATION OF A NEW COMMERCIAL IRMA FOR BONE-SPECIFIC ALKALINE-PHOSPHATASE DURING TREATMENT WITH HORMONE REPLACEMENT THERAPY AND CALCITONIN, Clinical chemistry, 42(6), 1996, pp. 973-974
Citation: Ob. Nielsen et K. Overgaard, ION GRADIENTS AND CONTRACTILITY IN SKELETAL-MUSCLE - THE ROLE OF ACTIVE NA+, K+ TRANSPORT, Acta Physiologica Scandinavica, 156(3), 1996, pp. 247-256
Citation: N. Munknielsen et al., POSTMENOPAUSAL BONE LOSS AND RESPONSE TO HORMONE REPLACEMENT THERAPY INDEPENDENT OF CLIMACTERIC SYMPTOMS, Menopause, 2(1), 1995, pp. 35-41
Citation: G. Boysen et K. Overgaard, THROMBOLYSIS IN ISCHEMIC STROKE - HOW FAR FROM A CLINICAL BREAKTHROUGH, Journal of internal medicine, 237(1), 1995, pp. 95-103
Citation: Bj. Riis et al., BIOCHEMICAL MARKERS OF BONE TURNOVER TO MONITOR THE BONE RESPONSE TO POSTMENOPAUSAL HORMONE REPLACEMENT THERAPY, Osteoporosis international, 5(4), 1995, pp. 276-280
Citation: Ma. Hansen et al., SPONTANEOUS POSTMENOPAUSAL BONE LOSS IN DIFFERENT SKELETAL AREAS - FOLLOWED UP FOR 15 YEARS, Journal of bone and mineral research, 10(2), 1995, pp. 205-210